Video

Dr. Annunziata on Efforts to Prevent Gynecologic Cancers

Christina M. Annunziata, MD, PhD, investigator, Women's Malignancies Branch, head, Translational Genomics Section, National Cancer Institute, discusses the importance on efforts being done to prevent gynecologic cancers.

Christina M. Annunziata, MD, PhD, investigator, Women's Malignancies Branch, head, Translational Genomics Section, National Cancer Institute, discusses focusing efforts to prevent gynecologic cancers.

Researchers need to think about treating patients earlier and determining how to prevent cancer from forming in the first place, she explains. There needs to be more examinations in high-risk groups and identify patients who are at risk for these gynecologic cancers—then work to help prevent a cancer diagnosis from occurring.

Progress is being made for therapies in the upfront and recurrent settings, but there needs to be more of a push in the prevention setting, she concludes.

Related Videos
Paolo Caimi, MD
Dr Oveisi on the Importance of Patient Counseling Prior to CAR T-Cell Therapy in Myeloma
Leo I. Gordon, MD
Janaki Neela Sharma, MD, University of Miami
Richard Kim, MD, Moffitt Cancer Center
Janaki Neela Sharma, MD, discusses CheckMate 901, and where nivolumab plus chemotherapy fits into the advanced urothelial cancer treatment paradigm.
David Rimm, MD, PhD, discusses current HER2 immunohistochemistry assays that are used in the management of breast cancer, and their shortcomings.
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Farrukh Awan, MD, discusses treatment considerations with the use of pirtobrutinib in previously treated patients with hematologic malignancies.